Selective 5HT3 antagonists and sensory processing: a systematic review

Ondansetron is a selective serotonin (5HT3) receptor antagonist that is under evaluation as an adjunctive treatment for schizophrenia, and a novel treatment for hallucinations in Parkinson’s disease. Ondansetron reverses sensory gating deficits and improves visuoperceptual processing in animal model...

Descripción completa

Detalles Bibliográficos
Autores principales: Tsitsipa, Eirini, Rogers, Jonathan, Casalotti, Sebastian, Belessiotis-Richards, Clara, Zubko, Olga, Weil, Rimona S., Howard, Robert, Bisby, James A., Reeves, Suzanne
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8882165/
https://www.ncbi.nlm.nih.gov/pubmed/35017671
http://dx.doi.org/10.1038/s41386-021-01255-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8882165/
https://www.ncbi.nlm.nih.gov/pubmed/35017671
http://dx.doi.org/10.1038/s41386-021-01255-4

Ejemplares similares